137 related articles for article (PubMed ID: 30150172)
21. [The dynamics of drug release from suppositories. Part 6: The effects of lipophil and hydrophilic suppository bases on the release of adeiphenin (author's transl)].
Pasich J; Brobnicka B; Kasprzyk A
Pharmazie; 1980; 35(7):416-7. PubMed ID: 6106209
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of paracetamol suppositories by a pharmacopoeial dissolution test--comments on methodology.
Janicki S; Sznitowska M; Zebrowska W; Gabiga H; Kupiec M
Eur J Pharm Biopharm; 2001 Sep; 52(2):249-54. PubMed ID: 11522493
[TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro diclofenac sodium evaluation after rectal application of soft gelatine capsules enabling application induced transformation (AIT) into a semisolid system of liquid crystals (SSLC) for controlled release.
Schneeweis A; Müller-Goymann CC
Pharm Res; 1997 Dec; 14(12):1726-9. PubMed ID: 9453060
[TBL] [Abstract][Full Text] [Related]
24. The release of isoconazole nitrate from different suppository bases: in-vitro dissolution, physicochemical and microbiological studies.
Asikoglu M; Ertan G; Cosar G
J Pharm Pharmacol; 1995 Sep; 47(9):713-6. PubMed ID: 8583380
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children.
Hanning SM; Matiz S; Krasser K; Orlu M; Dodoo C; Gaisford S; Tuleu C
Drug Deliv Transl Res; 2021 Jun; 11(3):944-955. PubMed ID: 32588280
[TBL] [Abstract][Full Text] [Related]
26. Formulation development of allopurinol suppositories and injectables.
Lee DK; Wang DP
Drug Dev Ind Pharm; 1999 Nov; 25(11):1205-8. PubMed ID: 10596359
[TBL] [Abstract][Full Text] [Related]
27. EVALUATION OF DICLOFENAC SODIUM SUSTAINED RELEASE MATRIX PELLETS: IMPACT OF POLYETHYLENE GLYCOLS MOLECULAR WEIGHT.
Ibrahim MA; Shazly GA
Acta Pol Pharm; 2015; 72(5):987-97. PubMed ID: 26665407
[TBL] [Abstract][Full Text] [Related]
28. The release of isoconazole nitrate from different suppository bases: in-vivo release of drug labelled with 99mTc in rabbits.
Asikoglu M; Ertan G; Ercan MT; Duman Y
J Pharm Pharmacol; 1995 Sep; 47(9):717-20. PubMed ID: 8583381
[TBL] [Abstract][Full Text] [Related]
29. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
Pasich J; Drobnicka B; Kasprzyk A
Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
31. Formulation effects on the mechanical and release properties of metronidazole suppositories.
Adegboye TA; Itiola OA
Afr J Med Med Sci; 2003 Sep; 32(3):247-51. PubMed ID: 15030082
[TBL] [Abstract][Full Text] [Related]
32. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
[TBL] [Abstract][Full Text] [Related]
33. Development of doxycycline hyclate suppositories and pharmacokinetic study in rabbits.
Christ AP; Biscaino PT; Lourenço RL; de Souza AB; Zimmermann ES; Adams AIH
Eur J Pharm Sci; 2020 Jan; 142():105141. PubMed ID: 31706017
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of diclofenac sodium sustained release matrix pellets: impact of polyethylene glycols molecular weight.
Ibrahim A; Shazly A
Acta Pol Pharm; 2014; 71(5):821-31. PubMed ID: 25362811
[TBL] [Abstract][Full Text] [Related]
35. Isoniazid release from suppositories compounded with selected bases.
Hudson KC; Asbill CS; Webster AA
Int J Pharm Compd; 2007; 11(5):433-7. PubMed ID: 23969524
[TBL] [Abstract][Full Text] [Related]
36. Release and rectal absorption of ethosuximide from suppositories in rabbits.
Ghazy FS; Mohamed MS; Kassem AA; Elhoseiny BM
Pharmazie; 1988 Jul; 43(7):484-5. PubMed ID: 3222279
[TBL] [Abstract][Full Text] [Related]
37. Formulation and Evaluation of Tramadol hydrochloride Rectal Suppositories.
Saleem MA; Taher M; Sanaullah S; Najmuddin M; Ali J; Humaira S; Roshan S
Indian J Pharm Sci; 2008 Sep; 70(5):640-4. PubMed ID: 21394263
[TBL] [Abstract][Full Text] [Related]
38. A two-way cross-over bioequivalence study comparing two products of diclofenac sodium suppositories in healthy human volunteers.
Hasan M; Otoom S; Najib N; Sallam el-S
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):263-5. PubMed ID: 15569270
[TBL] [Abstract][Full Text] [Related]
39. Improvement of availability of allopurinol from pharmaceutical dosage forms I - suppositories.
Samy EM; Hassan MA; Tous SS; Rhodes CT
Eur J Pharm Biopharm; 2000 Mar; 49(2):119-27. PubMed ID: 10704894
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the relationship between melting-related parameters and in vitro drug release from vaginal suppositories.
Bergren MS; Battle MM; Halstead GW; Theis DL
J Pharm Biomed Anal; 1989; 7(5):549-61. PubMed ID: 2490759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
